Biotech firm Vivus unveiled a would-be player this week in the US$3.7-billion erectile dysfunction market: avanafil, effective in just 15 – Read More...
By Dr. Robert Goldman Longevity News and Review provides readers with the latest information in breakthroughs pertaining to the extension – Read More...